Celldex Therapeutics reported $604.34M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Amgen USD 27.88B 1.15B Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Celldex Therapeutics USD 604.34M 44.06M Sep/2025
Glaxosmithkline GBP 23.98B 6.31B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025